TY - JOUR
T1 - Restoring endothelial function by targeting desert hedgehog downstream of klf2 improves critical limb ischemia in adults
AU - Caradu, Caroline
AU - Couffnhal, Thierry
AU - Chapouly, Candice
AU - Guimbal, Sarah
AU - Hollier, Pierre Louis
AU - Ducasse, Eric
AU - Bura-Rivière, Alessandra
AU - Dubois, Mathilde
AU - Gadeau, Alain Pierre
AU - Renault, Marie Ange
N1 - Funding Information:
This study was sponsored by the Toulouse University Hospital Centre and supported by a grant from the French Ministry of Health (Interregional Clinical Research Hospital Program PHRC-I 2009 N°RCB: 2009-A00889-48), the Société de Chirurgie Vasculaire et Endovasculaire de langue française, and the Fondation de France, Appels d’Offre Recherche sur les maladies Cardiovasculaires 2013 and 2018. Additionally, this study was co-funded by the Institut National de la Santé et de la Recherche Médicale and by the University of Bordeaux.
Publisher Copyright:
© 2018 American Heart Association, Inc.
PY - 2018
Y1 - 2018
N2 - Rationale: Klf (kruppel-like factor) 2 is critical to establish and maintain endothelial integrity. Objective: Therefore, determining upstream and downstream mediators of Klf2 would lead to alternative therapeutic targets in cardiovascular disease management. Methods and Results: Here we identify Dhh (desert hedgehog) as a downstream effector of Klf2, whose expression in endothelial cells (ECs) is upregulated by shear stress and decreased by in?ammatory cytokines. Consequently, we show that Dhh knockdown in ECs promotes endothelial permeability and EC activation and that Dhh agonist prevents TNF-a (tumor necrosis factor alpha) or glucose-induced EC dysfunction. Moreover, we demonstrate that human critical limb ischemia, a pathological condition linked to diabetes mellitus and in?ammation, is associated to major EC dysfunction. By recreating a complex model of critical limb ischemia in diabetic mice, we found that Dhh-signaling agonist signifcantly improved EC function without promoting angiogenesis, which subsequently improved muscle perfusion. Conclusion: Restoring EC function leads to signifcant critical limb ischemia recovery. Dhh appears to be a promising target, downstream of Klf2, to prevent the endothelial dysfunction involved in ischemic vascular diseases.
AB - Rationale: Klf (kruppel-like factor) 2 is critical to establish and maintain endothelial integrity. Objective: Therefore, determining upstream and downstream mediators of Klf2 would lead to alternative therapeutic targets in cardiovascular disease management. Methods and Results: Here we identify Dhh (desert hedgehog) as a downstream effector of Klf2, whose expression in endothelial cells (ECs) is upregulated by shear stress and decreased by in?ammatory cytokines. Consequently, we show that Dhh knockdown in ECs promotes endothelial permeability and EC activation and that Dhh agonist prevents TNF-a (tumor necrosis factor alpha) or glucose-induced EC dysfunction. Moreover, we demonstrate that human critical limb ischemia, a pathological condition linked to diabetes mellitus and in?ammation, is associated to major EC dysfunction. By recreating a complex model of critical limb ischemia in diabetic mice, we found that Dhh-signaling agonist signifcantly improved EC function without promoting angiogenesis, which subsequently improved muscle perfusion. Conclusion: Restoring EC function leads to signifcant critical limb ischemia recovery. Dhh appears to be a promising target, downstream of Klf2, to prevent the endothelial dysfunction involved in ischemic vascular diseases.
KW - Endothelial cells
KW - Hedgehogs
KW - Inflammation
KW - Peripheral arterial disease
KW - Therapeutics
UR - http://www.scopus.com/inward/record.url?scp=85055602597&partnerID=8YFLogxK
U2 - 10.1161/CIRCRESAHA.118.313177
DO - 10.1161/CIRCRESAHA.118.313177
M3 - Article
C2 - 30355159
AN - SCOPUS:85055602597
SN - 0009-7330
VL - 123
SP - 1053
EP - 1065
JO - Circulation Research
JF - Circulation Research
IS - 9
ER -